Table 2.

Correlation of cCD20 level with clinical parameters in patients with CLL

Variablep (r value)
Hemoglobin level .02 (−0.18)* 
β2-microglobulin level .006 (0.23)* 
RAI: 0, I-II, III-IV .01 
Binet: A, B, C .004 
Platelet count .004 (−0.22)* 
CD19+/CD38+, % .03 (0.20)* 
Splenomegaly .07 
Hepatomegaly .25 
Node enlargement .11 
Age .53 (0.05)* 
Lymphocyte count .71 (−0.03)* 
White blood cell count .33 (−0.07)* 
Sex .66 
Variablep (r value)
Hemoglobin level .02 (−0.18)* 
β2-microglobulin level .006 (0.23)* 
RAI: 0, I-II, III-IV .01 
Binet: A, B, C .004 
Platelet count .004 (−0.22)* 
CD19+/CD38+, % .03 (0.20)* 
Splenomegaly .07 
Hepatomegaly .25 
Node enlargement .11 
Age .53 (0.05)* 
Lymphocyte count .71 (−0.03)* 
White blood cell count .33 (−0.07)* 
Sex .66 

r value indicates correlation coefficient.

*

Spearman rank correlation test.

Kruskal-Wallis test.

Wilcoxon rank sum test.

Close Modal

or Create an Account

Close Modal
Close Modal